StockData
BioAdaptives, Inc. logo

BioAdaptives, Inc. (BDPT) stock

BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.00−0.00 (-5.56%)

Close on Oct 19, 2026Market cap $478.03KP/E –Yield –

BioAdaptives operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

BioAdaptives's operating income for the twelve months ending Jun 30, 2026 was -$909.20K. For fiscal 2025 it was -$1.04M. The highest annual figure on record is -$227.28K in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.04M–
FY2024Dec 31, 2024-$602.09K–
FY2023Dec 31, 2023-$228.92K–
FY2022Dec 31, 2022-$421.90K–
FY2015Dec 31, 2015-$227.28K–
FY2014Dec 31, 2014-$2.44M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$197.18K–
Q1 FY2026Mar 31, 2026-$198.22K–
Q4 FY2025Dec 31, 2025-$248.12K–
Q3 FY2025Sep 30, 2025-$265.69K–
Q2 FY2025Jun 30, 2025-$279.22K–
Q1 FY2025Mar 31, 2025-$249.15K–
Q4 FY2024Dec 31, 2024-$337.34K–
Q3 FY2024Sep 30, 2024-$121.94K–
Q2 FY2024Jun 30, 2024-$92.98K–
Q1 FY2024Mar 31, 2024-$49.83K–
Q4 FY2023Dec 31, 2023-$61.78K–
Q3 FY2023Sep 30, 2023-$92.21K–
Q2 FY2023Jun 30, 2023-$55.95K–
Q1 FY2023Mar 31, 2023-$18.98K–
Q3 FY2016Sep 30, 2016-$26.31K–
Q2 FY2016Jun 30, 2016-$33.21K–
Q1 FY2016Mar 31, 2016-$80.92K–
Q4 FY2015Dec 31, 2015-$48.51K–
Q3 FY2015Sep 30, 2015-$40.14K–

More BioAdaptives figures

See a number that looks wrong?